Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5287-5293

  Gu, Xiao Yan ^a   Wang, Jun ^b   Luo, Yi Zhou ^a   Du, Qiang ^c   Li, Ruo Ran ^d   Shi, Hui ^e   Yu, Tian Pei ^a  

^a 454th Hospital of Chinese PLA   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d XUZHOU CENTRAL HOSPITAL   (China)

^e JINLING HOSPITAL   (China)

Author keywords

Apoptosis; miR 150; Non small cell lung cancer; Proliferation

Indexed keywords

MICRORNA; MICRORNA 150; PROTEIN BAK; PROTEIN BAK1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MOLECULAR INTERACTION; ONCOGENE; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR GROWTH; UPREGULATION;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; LUNG NEOPLASMS; MICRORNAS;

EID: 84904759617     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1688-4     Document Type: Article

References (16)

1. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 2001;61:3986-97. (Pubitemid 32720961)
2. Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, et al. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol. 2004;22:3230-7. (Pubitemid 41103677)
3. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479-85. (Pubitemid 30085163)
4. Zhu X, Zhang X, Wang H, Song Q, Zhang G, Yang L, et al. MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells. Oncol Rep. 2012;28(1):218-24.
5. Shi L, Jiang D, Sun G, Wan Y, Zhang S, Zeng Y, et al. miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. J Neuro Oncol. 2012;110(2):155-62.
6. Zhang N, Wei X, Xu L. miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett. 2013;587(15):2346-51.
7. Li YJ, Zhang YX, Wang PY, Chi YL, Zhang C, Ma Y, et al. Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol Rep. 2012;27(1):129-34.
8. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K, et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 2010;392(3):340-5.
9. Bousquet M, Zhuang G, Meng C, Ying W, Cheruku PS, Shie AT, et al. miR-150 blocks MLL-AF9-associated leukemia through oncogene repression. Mol Cancer Res. 2013;11(8):912-22.
10. Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, et al. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut. 2012;61(10):1447-53.
11. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A. 2007;104(50):19983-8.
12. Lin PY, Yu SL, Yang PC. MicroRNA in lung cancer. Br J Cancer. 2010;103:1144-8.
13. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell. 2005;120(5):635-47. (Pubitemid 40343076)
14. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673-7. (Pubitemid 46676103)
15. Kim YA, Xiao D, Xiao H, Powolny AA, Lew KL, Reilly ML, et al. Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol Cancer Ther. 2007;6(5):1599-609. (Pubitemid 46954027)
16. Yoshino T, Shiina H, Urakami S, Kikuno N, Yoneda T, Shigeno K, et al. Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Clin Cancer Res. 2006;12(20 Pt 1):6116-24. (Pubitemid 44703777)